{
    "paper_id": "PMC7169203",
    "metadata": {
        "title": "SARS: ventilatory and intensive care",
        "authors": [
            {
                "first": "Loretta",
                "middle": [
                    "YC"
                ],
                "last": "YAM",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Rong",
                "middle": [
                    "Chang"
                ],
                "last": "CHEN",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Nan",
                "middle": [
                    "Shan"
                ],
                "last": "ZHONG",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The initial fever and respiratory symptoms of severe acute respiratory syndrome (SARS) often progress rapidly to acute respiratory failure (ARF) with varying levels of severity. Reported rates of intensive care (ICU) admission vary between 19 to 32%.\n1\n, \n2\n, \n3\n, \n4\n, \n5\n, \n6\n Early ARF usually peaks by 8 days after symptom onset.\n1\n, \n2\n But can be delayed with a protracted course.\n2\n In the ICU, mortality rates similar to or lower than those reported for the acute respiratory distress syndrome (ARDS)\n7\n have been reported.\n1\n, \n5\n The following recommendations on the ventilatory and ICU management of SARS are based on published data as well as our local experience.",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "\n1Patients who meet the criteria for acute respiratory distress syndrome (ARDS, defined by PaO2/FiO2\u2264 200 mmHg) should be cared for in an ICU. Depending on availability, observation in a high dependency (HDU) setting or ICU is indicated in those who meet the criteria for acute lung injury ((ALI), defined by PaO2/FiO2 > 200\u2013300 mmHg, or in those who presented with tachypnoea (respiratory rate > 30/min) and more than 50% progression of chest (bilateral or multilobular) shadows within 48 hours.)\n8\n\n2Patients who develop signs of sepsis, septic shock or multiorgan failure. As SARS is characteristically accompanied by single organ (respiratory) failure\n1\n multiorgan failure is usually a result of superimposed hospital\u2010acquired bacterial infection.\n",
            "cite_spans": [],
            "section": "INDICATIONS FOR ICU CARE",
            "ref_spans": []
        },
        {
            "text": "There is no specific treatment currently available for SARS. Empirical therapy includes broad\u2010spectrum antibiotics and various antiviral agents, with no proven efficacy.\n3\n, \n4\n\n,\n\n6\n, \n9\n\n,\n\n10\n Based on the hypothesis that the respiratory failure of SARS is secondary to an immunopathological phenomenon,\n10\n anti\u2010inflammatory agents like corticosteriods have been widely used in Canada,\n4\n China\n5\n, \n12\n, \n13\n, \n14\n and Hong Kong.\n3\n, \n6\n\n,\n\n9\n, \n10\n In particular, short\u2010term intravenous high dose (pulsed) methylprednisolone (500\u20131000 mg) has been advocated to treat progressive pulmonary infiltrates and hypoxaemia\n9\n, \n11\n\n,\n\n13\n with good response reported.\n5\n, \n9\n\n,\n\n13\n, \n14\n Half of the critically ill patients with SARS might benefit from initial intravenous corticosteroid.\n15\n Interferon and immunoglobin (including Pentaglobin)\n11\n, \n14\n\n,\n\n16\n have also been used.",
            "cite_spans": [],
            "section": "Pharmacological agents ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": []
        },
        {
            "text": "Oxygen was required in 50\u201385% of SARS patients\n9\n, \n12\n\n,\n\n14\n and may be delivered via nasal cannulae at 1\u20136 L per minute (LPM) or via non\u2010rebreathing masks (NRM) at 8\u201315 LPM. Patients with continuing deterioration of respiratory status will require ICU care.",
            "cite_spans": [],
            "section": "Oxygen supplementation ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": []
        },
        {
            "text": "Non\u2010invasive ventilation (NIV) is a standard mode of ventilatory assist in early ARF and ARDS due to various causes.\n17\n, \n18\n While mortality benefit was not shown, NIV could reduce intubation rate\n18\n and thus the complications associated with intubation and mechanical ventilation. This may be of particular advantage in SARS, where anti\u2010inflammatory agents could predispose the patients to ventilator\u2010associated pneumonia (VAP).",
            "cite_spans": [],
            "section": "Non\u2010invasive ventilation ::: Ventilatory care ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": []
        },
        {
            "text": "Despite concern about potential aerosol generation, NIV has been reported to be effective in the treatment of SARS\u2010related ARF without posing infection risks to HCWs.\n9\n, \n11\n, \n13\n, \n14\n A study reported that NIV was indicated in ALI and early ARDS when desaturation (SaO2 < 93%) occurred despite oxygen supplementation (> 3\u20135 L/m), with persistent tachypnoea (\u2265 30/min) and progressive deterioration on CXR.\n11\n Intubation could be avoided in up to two\u2010thirds of cases in a Hong Kong series (unpubl. data, 2003) and in two studies from Guangzhou.\n5\n, \n19\n The usual contraindications to NIV apply, including disturbed consciousness, uncooperative patient, high aspiration risk and haemodynamic instability.",
            "cite_spans": [],
            "section": "Non\u2010invasive ventilation ::: Ventilatory care ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": []
        },
        {
            "text": "Conventional mechanical ventilators (pressure support mode), BiPAP\u00ae or continuous positive airway pressure (CPAP) machines, preferably with leak compensation capability, may be used to deliver NIV. SARS\u2010related ARF responds readily to low positive pressures of CPAP 4\u201310 cm H2O\n5\n or inspiratory pressures (IPAP) of < 10 cm H2O and expiratory pressures (EPAP) of 4\u20136 cm water. Higher pressures should be avoided because of the common finding of spontaneous pneumomediastinum and pneumothorax in SARS.\n10\n The incidence of NIV\u2010associated barotrauma ranged from 6.6%\n20\n to 15% (unpubl. data, 2003).",
            "cite_spans": [],
            "section": "Non\u2010invasive ventilation ::: Ventilatory care ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": []
        },
        {
            "text": "To reduce aerosol generation, exhalation ports that generate round\u2010the\u2010tube airflow (e.g. Whisper\u2010Swivel II, (Respironics, Murrysville, Pennsylvania, USA)) are preferred to those producing jet outflow. A viral\u2010bacterial filter interposed between the mask and the exhalation port could further reduce environmental contamination. Strict adherence to infection control measures including isolation,\n13\n use of appropriate personal protective equipment (PPE) and negative pressure environment\n9\n had been reported to eliminate cross\u2010infection to healthcare workers. Further details on infection control are shown in Table 1.",
            "cite_spans": [],
            "section": "Non\u2010invasive ventilation ::: Ventilatory care ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": [
                {
                    "start": 613,
                    "end": 620,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Patients who fail to tolerate NIV or fail NIV with progressive dyspnoea, tachypnoea and hypoxaemia should be intubated and mechanically ventilated.\n5\n, \n11\n Similar indications apply if NIV had not been used prior to intubation. Both pressure and volume control ventilation have been used to treat SARS\u2010related ARF.\n2\n Care should be taken to keep the tidal volume low at 5\u20136 mL/kg, and alveolar (plateau) pressures below 30 cm H2O.\n2\n PEEP levels should be titrated to as low as possible to maintain appropriate oxygenation. Since physical activity or even coughing may result in severe desaturation, sufficient sedation during early mechanical ventilation is useful to eliminate anxiety, thus improving pulmonary oxygenation.\n21\n A high rate of barotrauma (34%) had been reported,\n1\n again highlighting the need to avoid excessive volumes and pressures. Permissive hypercapnia resulting from cautious ventilator management necessitated short\u2010term neuromuscular blockade in 52\u201370% of ventilated cases.\n1\n, \n2\n Other ventilator modes used include airway pressure release ventilation and high frequency oscillatory ventilation but results have not been reported.\n2\n\n",
            "cite_spans": [],
            "section": "Mechanical ventilation (MV) ::: Ventilatory care ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": []
        },
        {
            "text": "Apart from barotrauma, common complications of mechanical ventilation include ventilator\u2010associated pneumonia, acute renal failure, deep vein thrombosis and pulmonary embolism.\n2\n Low baseline PaO2/FiO2 ratios and high APACHE II scores were the only predictors for protracted ARDS and death in one study.\n2\n ICU mortality rates were high: 34\u201353% at 28 days, when some patients were still being ventilated.\n1\n, \n2\n To improve survival, research is required to identify early all SARS patients who may progress to severe ARDS and to develop effective treatment.",
            "cite_spans": [],
            "section": "Mechanical ventilation (MV) ::: Ventilatory care ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": []
        },
        {
            "text": "Meticulous infection control measures (Table 1) are mandatory in the care of ventilated SARS patients in ICU, where HCW are exposed to high risk procedures like bag\u2010mask ventilation, NIV, endotracheal intubation, actual or potential circuit disconnections, suctioning, tracheostomy and bronchoscopy with or without bronchoalveolar lavage. The duration of manual ventilation during resuscitation procedures should be reduced to a minimum. Endotracheal intubation should be performed by the most skilled person available\n22\n using rapid sequence induction: risk of aerosol generation is lowest when the patient is paralysed. All special precautions for ICU patients must be complied with. Contrary to recommendations to avoid NIV and nebulised therapy,\n22\n NIV has not been reported to be associated with increased infection risk for HCW, and doubts have been raised about the role of nebulised treatment on the spread of SARS within the hospital.\n24\n On the other hand, it is always prudent to limit opportunities for HCW exposure and to perform aerosol generating procedures in an airborne isolation environment.\n25\n\n",
            "cite_spans": [],
            "section": "Mechanical ventilation (MV) ::: Ventilatory care ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": [
                {
                    "start": 39,
                    "end": 46,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "In addition to ensuring the safety of HCWs, timely psychological support is critical to maintain staff morale.\n2\n The above strategies had been effective in preventing infection in ICU HCWs in hospitals in Singapore\n2\n and Hong Kong, and in the latter case over 80 HCWs exposed to NIV and mechanical ventilation of SARS patients were proved to be serologically negative for SARS\u2010CoV after the outbreak (unpubl. data, 2003).",
            "cite_spans": [],
            "section": "Mechanical ventilation (MV) ::: Ventilatory care ::: MANAGEMENT OF RESPIRATORY FAILURE",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Infection control precautions in the ICU\n22\n, \n23\n, \n25\n\n\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: Powered air purifying respirator (PAPR) (Air\u2010mate). (a) Frontal view. (b) Back view of battery with HEPA filter and duct supplying purified air to hood unit.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: (a) Closed circuit (in\u2010line) suction system with heat and moisture exchanger (HME) shown as white flexitube connected to a viral/bacterial filter. (b) Servo\u2010Evac 180 for connection to exhalation port of ventilator. The Servo\u2010Evac 180 consists of a connection to the ventilator's expiratory port (curved flexitube) which empties expired air into a Evac Bag, which has a one\u2010way valve through which expired gas can be removed via an evacuation hose (white tube) connected to a suction source. The straight flexitube is open to the atmosphere to ensure the patient is not subjected to undue negative pressure or excessive resistance in case the suction sources is interrupted.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Critically ill patients with severe acute respiratory distress syndrome",
            "authors": [],
            "year": 2003,
            "venue": "JAMA",
            "volume": "290",
            "issn": "",
            "pages": "367-73",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Clinical progression and viral load in a community outbreak of coronavirus associated SARS pneumonia: a prospective study",
            "authors": [],
            "year": 2003,
            "venue": "Lancet",
            "volume": "316",
            "issn": "",
            "pages": "1767-72l",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "SARS treatment: experience from a team in Guangdong, China",
            "authors": [],
            "year": 2003,
            "venue": "Chin. Med. J.",
            "volume": "116",
            "issn": "",
            "pages": "838-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Clinical analysis of 45 patients with severe acute respiratory distress syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Chin. Med. J.",
            "volume": "116",
            "issn": "",
            "pages": "819-22",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China",
            "authors": [],
            "year": 2003,
            "venue": "J. Med. Microb.",
            "volume": "52",
            "issn": "",
            "pages": "715-20",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China",
            "authors": [],
            "year": 2003,
            "venue": "Chin. Med. J.",
            "volume": "116",
            "issn": "",
            "pages": "811-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Corticosteroid in the management of severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Chin. J. Intern. Med.",
            "volume": "42",
            "issn": "",
            "pages": "1-2",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Effect of \u03b3\u2010immunoglobin administration on the hospitalization time in patients with severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Guangdong Med. J.",
            "volume": "24",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Non\u2010invasive ventilation in acute respiratory failure",
            "authors": [],
            "year": 2002,
            "venue": "Thorax",
            "volume": "57",
            "issn": "",
            "pages": "192-211",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Noninvasive ventilation in acute respiratory failure\u2014a metaanalysis update",
            "authors": [],
            "year": 2002,
            "venue": "Crit. Care Med.",
            "volume": "30",
            "issn": "",
            "pages": "555-62",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Noninvasive continuous positive airway pressure ventilation in the management of critical patients with severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Guangdong Med. J.",
            "volume": "24",
            "issn": "suppl.",
            "pages": "91-2",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "JAMA",
            "volume": "290",
            "issn": "",
            "pages": "374-80",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Management of critical severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Chin. J. Tuberc. Respir. Dis.",
            "volume": "26",
            "issn": "",
            "pages": "329-33",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Mechanical ventilation strategies in critical SARS patients",
            "authors": [],
            "year": 2003,
            "venue": "Chin. J. Emerg. Med.",
            "volume": "12",
            "issn": "",
            "pages": "369-72",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "ICU management of severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Intensive Care Med.",
            "volume": "29",
            "issn": "",
            "pages": "870-5",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "A cluster or severe acute respiratory syndrome among medical students exposed to a single patient in Hong Kong",
            "authors": [],
            "year": 2003,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "",
            "authors": [],
            "year": 1994,
            "venue": "Guidelines for Preventing the Transmission of Mycobacterium Tuberculosis in Health Care Facilities.",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "A major outbreak of severe acute respiratory syndrome in Hong Kong",
            "authors": [],
            "year": 2003,
            "venue": "N. Engl. J. Med.",
            "volume": "348",
            "issn": "",
            "pages": "1986-94",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Clinical features and outcomes of 144 patients with SARS in the greater Toronto area",
            "authors": [],
            "year": 2003,
            "venue": "JAMA",
            "volume": "289",
            "issn": "",
            "pages": "2801-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "A retrospective study of 78 patients with severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Chin. Med. J.",
            "volume": "116",
            "issn": "",
            "pages": "805-10",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Characteristics and outcome in adult patients receiving mechanical ventilation: a 28\u2010day international study",
            "authors": [],
            "year": 2002,
            "venue": "JAMA",
            "volume": "287",
            "issn": "",
            "pages": "345-55",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Development of a standard treatment protocol for severe acute respiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "1615-7",
            "other_ids": {
                "DOI": []
            }
        }
    }
}